| Sep 23 |
Here’s Why AstraZeneca PLC (AZN) Surged in Q2
|
| Sep 23 |
AstraZeneca, Daiichi’s Enhertu successor faces more questions after latest stumble
|
| Sep 23 |
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
|
| Sep 23 |
Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
|
| Sep 23 |
AstraZeneca and Daiichi Sankyo report data from Phase III breast cancer trial
|
| Sep 23 |
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
|
| Sep 21 |
Novartis' Pluvicto expected to dominate prostate cancer radiopharmaceutical market
|
| Sep 20 |
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
|
| Sep 20 |
FLUMIST approved for self-administration in the US
|
| Sep 20 |
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
|
